New antibiotic Ramazol for treatment of Clostridium difficile

Author: admin
Published date: 20 January 2019
Category:
Innovation
Share

What you need to know

Research by Boulos & Cooper Pharmaceuticals, US- based Product Safety Labs and ToxStrategies and Flinders University shows potential of Ramazol in animal studies.

Significant proportion of hamsters survived the infection of a lethal dose of Clostridium difficile following the treatment of the new antibiotic Ramizol. Rat studies showed no serious side effects or changes in weight after treatment.

Full article Infection Control Today

Stay Updated

Stay connected to keep up with the latest on antimicrobial resistance.

Name(Required)